THE EFFECTS OF DANSHEN (SALVIA-MILTIORRHIZA) ON WARFARIN PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN ENANTIOMERS IN RATS

被引:87
|
作者
CHAN, K
LO, ACT
YEUNG, JHK
WOO, KS
机构
[1] CHINESE UNIV HONG KONG,DEPT PHARMACOL,HONG KONG,HONG KONG
[2] CHINESE UNIV HONG KONG,DEPT MED,HONG KONG,HONG KONG
关键词
D O I
10.1111/j.2042-7158.1995.tb05819.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of Danshen (Salvia miltiorrhiza), a popular traditional Chinese medicinal herb on the pharmacokinetics and pharmacodynamics of R- and S-warfarin stereoisomers were studied in rats. After a single oral dose of racemic warfarin (2 mg kg(-1)), treatment with oral Danshen extract (5 g kg(-1) twice daily) for 3 days significantly altered the overall pharmacokinetics of both R- and S-warfarin and increased the plasma concentrations of both enantiomers over a period of 24 h and the prothrombin time over 2 days. At steady-slate levels of racemic warfarin (0.2 mg kg day(-1) for 5 days) the 3-day treatment of Danshen extract (5 g kg(-1), twice daily) not only prolonged the prothrombin time but also increased the steady-state plasma concentrations of R- and S-warfarin. The results indicate that Danshen extracts can increase the absorption rate constant, area under plasma concentration-time curves, maximum concentrations and elimination half-lives, but decreases the clearances and apparent volume of distribution of both R- and S-warfarin. The pharmacokinetic and pharmacodynamic interactions of warfarin during co-treatment with Danshen extract observed in this study indicate an explanation for the clinically observed incidents of exaggerated warfarin adverse effects when traditional Chinese medicinal herbs or herbal products such as Danshen and Danggui (observed in a previous study) were co-administered.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 50 条
  • [41] COMPARATIVE EFFECTS OF RANITIDINE AND CIMETIDINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN MAN
    TOON, S
    HOPKINS, KJ
    GARSTANG, FM
    ROWLAND, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (02) : 165 - 172
  • [42] STRUCTURE ELUCIDATION AND TOTAL SYNTHESIS OF NEW TANSHINONES ISOLATED FROM SALVIA-MILTIORRHIZA BUNGE (DANSHEN)
    CHANG, HM
    CHENG, KP
    CHOANG, TF
    CHOW, HF
    CHUI, KY
    HON, PM
    TAN, FWL
    YANG, Y
    ZHONG, ZP
    LEE, CM
    SHAM, HL
    CHAN, CF
    CUI, YX
    WONG, HNC
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (11): : 3537 - 3543
  • [43] Effects of Amlodipine on the Pharmacokinetics of Warfarin after Oral and Intravenous Administration of Warfarin in Rats
    Choi, Dong-Hyun
    Piao, Yong-Ji
    Choi, Eun-Joo
    Choi, Jun-Shik
    Burm, Jin-Pil
    [J]. BIOMOLECULES & THERAPEUTICS, 2011, 19 (04) : 493 - 497
  • [44] Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction
    Lin T.-H.
    Hsieh C.-L.
    [J]. Chinese Medicine, 5 (1):
  • [45] The Effect of Compound Danshen Dripping Pills on the Pharmacokinetics of Steady-state Warfarin in Rats
    ZHANG Ling 1
    2.Tasly R&D Institute
    [J]. Medicinal Plant, 2012, (08) : 64 - 67
  • [46] Effects of CYP2C11 gene knockout on the pharmacokinetics and pharmacodynamics of warfarin in rats
    Ye, Huanying
    Sui, Danjuan
    Liu, Wei
    Yuan, Yuannan
    Ouyang, Zhen
    Wei, Yuan
    [J]. XENOBIOTICA, 2019, 49 (12) : 1478 - 1484
  • [47] Effects of Cucurbitacin E, a Tetracyclic Triterpene Compound from Cucurbitaceae, on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats
    Ding, Tonggui
    Zhang, Yuanjin
    Chen, Ang
    Tang, Yu
    Liu, Mingyao
    Wang, Xin
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (05) : 385 - 389
  • [48] Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin
    Eunice Yuen
    Ivelina Gueorguieva
    Stephen Wise
    Danny Soon
    Leon Aarons
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2010, 37 : 3 - 24
  • [49] Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin
    Padhi D.
    Sullivan J.T.
    [J]. Drugs in R & D, 2007, 8 (2) : 79 - 87
  • [50] MOEXIPRIL DOES NOT ALTER THE PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN
    VANHECKEN, A
    VERBESSELT, R
    DEPRE, M
    TJANDRAMAGA, TB
    ANGEHRN, J
    CAWELLO, W
    DESCHEPPER, PJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (03) : 291 - 293